✉news WorldUS Politics first seen 5 h ago, last 3 h ago, peak #20
Two-Year Data for Alopecia Drug LEQSELVI Shows Sustained Efficacy
Original: New LEQSELVI® (deuruxolitinib) Two-Year Data in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026
Sun Pharmaceutical announced two-year clinical data for LEQSELVI (deuruxolitinib) in severe alopecia areata, presented at the EADV Congress 2026. The results showed sustained efficacy and a consistent safety profile in patients over the extended treatment period. The findings reinforce the drug's long-term value for people with severe hair loss, though discussion so far appears limited to the announcement itself.
Why now: unclear
Sun PharmaceuticalLEQSELVIdeuruxolitinibEADV Congress 2026alopecia areata
Rank over time, top of the chart is #1. 2 snapshots from 5 h ago to 3 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/618368